Scage Future ADRSCAG
Price$0.22

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $11.1M+82.0% YoYTTM through 30 Jun 2025
Net Income -$12.9MTTM through 30 Jun 2025
Free Cash Flow -$5.9MTTM through 30 Jun 2025

Margins

Current
Gross Margin-6.4%
EBITDA Margin-117.9%
Operating Margin-120.6%
Net Margin-116.4%

Returns

245.7%ROE
-48.9%ROA

Balance Sheet Health

Debt / Equity-1.83x
Current Ratio0.20x
Net Debt$15.3M
Cash & Equivalents$90.8K

Quality Metrics

Altman Z-Score-3.91
Piotroski F-Score2 / 9
FCF Margin-53.1%

Multi-Year Trend

Revenue
'23'24'25
FY2025: $11.1M
Diluted EPS-$0.18TTM
'23'24'25
FY2025: $-0.18

Dividend

No dividend

Capital Allocation

R&D Spend$1.5M
Capex Intensity0.1%

Segment Performance

No segment data available.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.